Uncategorized
VIDEO: Quarterly dosing beneficial for some AMD patients
HONOLULU — At the Association for Research in Vision and Ophthalmology meeting here, David A. Eichenbaum, MD, discusses how anti-VEGF treatments can be extended to quarterly dosing rather than monthly in patients with neovascular age-related macular degeneration.